Nimbus Nips At BMS’s Heels With Psoriasis Results For TYK2 Inhibitor

 
• By Alaric DeArment
  
Nimbus announced positive results from its Phase IIb study of NDI-034858 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D